End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
13,600 ARS | +0.74% | +7.13% | +50.99% |
05-28 | CureVac, GSK Begin Dosing in Phase 2 Study for Seasonal Influenza Vaccine Candidate | MT |
05-27 | US, European nations consider vaccinating workers exposed to bird flu | RE |
Business Summary
Number of employees: 70,212
Sales per Business
GBP in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Commercial Operations
100.0
%
| 29,324 | 100.0 % | 30,328 | 100.0 % | +3.42% |
Sales per region
GBP in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
52.2
%
| 14,542 | 49.6 % | 15,820 | 52.2 % | +8.79% |
Rest of World
45.6
%
| 14,087 | 48.0 % | 13,815 | 45.6 % | -1.93% |
United Kingdom
2.3
%
| 695 | 2.4 % | 693 | 2.3 % | -0.29% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Emma Walmsley
CEO | Chief Executive Officer | 55 | 30/04/10 |
Julie Brown
DFI | Director of Finance/CFO | 62 | 30/04/23 |
James Ford
CMP | Compliance Officer | - | 31/07/95 |
Amy Altshul
CTO | Chief Tech/Sci/R&D Officer | - | - |
Chief Tech/Sci/R&D Officer | - | 31/12/17 | |
Tony Wood
CTO | Chief Tech/Sci/R&D Officer | - | 31/07/17 |
Hal Barron
BRD | Director/Board Member | 62 | 31/12/17 |
David Redfern
PRN | Corporate Officer/Principal | 57 | 31/12/93 |
Frannie DeFranco
PRN | Corporate Officer/Principal | - | 31/08/10 |
Claire Lund
PRN | Corporate Officer/Principal | - | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Julie Brown
DFI | Director of Finance/CFO | 62 | 30/04/23 |
Jonathan Symonds
CHM | Chairman | 66 | 31/08/19 |
Hal Barron
BRD | Director/Board Member | 62 | 31/12/17 |
Vishal Sikka
BRD | Director/Board Member | 57 | 17/07/22 |
Wendy Becker
BRD | Director/Board Member | 58 | 30/09/23 |
Charles Bancroft
BRD | Director/Board Member | 65 | 30/04/20 |
Anne Beal
BRD | Director/Board Member | 62 | 05/05/21 |
Emma Walmsley
CEO | Chief Executive Officer | 55 | 30/04/10 |
Director/Board Member | 66 | 31/08/22 | |
Jesse Goodman
BRD | Director/Board Member | 72 | 31/12/15 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 4,314,108,510 | 4,078,458,763 ( 94.54 %) | 169,171,155 ( 3.921 %) | 94.54 % |
Holdings
Name | Equities | % | Valuation |
---|---|---|---|
127,054,524 | 75.00% | 3,178,181,250 $ | |
HALEON PLC 4.22% | 385,320,110 | 4.22% | 1,638,015,054 $ |
263,029,794 | 82.59% | 94,201,490 $ | |
HALEON PAKISTAN LIMITED 85.79% | 100,423,259 | 85.79% | 87,258,774 $ |
LYELL IMMUNOPHARMA, INC. 11.87% | 30,253,189 | 11.87% | 66,557,016 $ |
WAVE LIFE SCIENCES LTD. 11.44% | 13,983,761 | 11.44% | 66,283,027 $ |
VIR BIOTECHNOLOGY, INC. 6.29% | 8,550,954 | 6.29% | 65,243,779 $ |
GLAXOSMITHKLINE S.A.E 91.20% | 76,161,378 | 91.20% | 47,877,327 $ |
CUREVAC N.V. 7.41% | 16,591,937 | 7.41% | 38,327,374 $ |
DONG-A ST CO., LTD. 8.17% | 722,016 | 8.17% | 35,314,582 $ |
Company contact information
Group companies
Name | Category and Sector |
---|---|
GlaxoSmithKline Asia Pvt Ltd.
GlaxoSmithKline Asia Pvt Ltd. Pharmaceuticals: MajorHealth Technology Part of GSK Plc, GlaxoSmithKline Asia Pvt Ltd. is an Indian company that produces bacterial and virus vaccines and other pharmaceutical products. The company is based in Gurgaon, India. |
Pharmaceuticals: Major
|
GSK Capital KK
|
Finance/Rental/Leasing
|
Horlicks Ltd.
Horlicks Ltd. Beverages: AlcoholicConsumer Non-Durables Horlicks Ltd. manufactures and distributes infant food products. The products it offers are Horlicks traditional, light and light chocolate. The company was founded on December 11, 1925 and is headquartered in Brentford, the United Kingdom. |
Beverages: Alcoholic
|
GlaxoSmithKline GmbH & Co. KG
GlaxoSmithKline GmbH & Co. KG Pharmaceuticals: MajorHealth Technology Part of GSK Plc, GlaxoSmithKline GmbH & Co. KG is a German pharmaceutical company. The company is based in Munich, Germany. The CEOs of the company are Jean-Bernard Siméon, Adrian Bauer. |
Pharmaceuticals: Major
|
Setfirst Ltd.
Setfirst Ltd. Financial ConglomeratesFinance Part of GSK Plc, Setfirst Ltd. functions as an investment holding British company. The company is based in Middlesex, UK. |
Financial Conglomerates
|
GlaxoSmithKline Pte Ltd.
GlaxoSmithKline Pte Ltd. Pharmaceuticals: OtherHealth Technology GlaxoSmithKline Pte Ltd. engages in pharmaceutical products. It provides prescription medicines, vaccines, and consumer healthcare services. The company is headquartered in Gateway West, Singapore. |
Pharmaceuticals: Other
|
SmithKline Beecham Overseas Ltd.
SmithKline Beecham Overseas Ltd. MiscellaneousMiscellaneous Founded in 1990, SmithKline Beecham Overseas Ltd. is a British holdings company that operates as a subsidiary of GSK Plc. The company is based in Middlesex, UK. |
Miscellaneous
|
GlaxoSmithKline Capital Plc
|
Finance/Rental/Leasing
|
GlaxoSmithKline Export Ltd.
GlaxoSmithKline Export Ltd. Medical DistributorsDistribution Services Part of GSK Plc, GlaxoSmithKline Export Ltd. is a British biopharma company founded in 1989. The company is based in Middlesex, UK. GlaxoSmithKline Export aims to unite science, technology, and talent to get ahead of disease together. The company's pipeline is focused on unlocking the science of the immune system and advanced technologies to develop innovative vaccines and medicines. |
Medical Distributors
|
Sector
Sales per Business
Sales per region
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+38.59% | 727B | |
-7.89% | 354B | |
+15.66% | 328B | |
+0.24% | 277B | |
+13.47% | 243B | |
+7.35% | 205B | |
-6.42% | 203B | |
+4.23% | 164B | |
-1.70% | 164B |
- Stock Market
- Equities
- GSK Stock
- GSK Stock
- Company GSK plc